Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

1 treatments under study, led by Exposure Not Intervention Sarscov2 Infection

Research Leaders

5 sponsors active, led by European Union

Related Conditions

Often studied with 5 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

Trial Status

Completed1
Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (2)

Showing 2 of 2 trials
NCT06939556Recruiting

High-throughput Serological Testing of Antibodies Platform

NCT04330261Completed

Clinical Characteristics and Outcomes of Pediatric COVID-19

Showing all 2 trials

Research Network

Common Treatments

  • Exposure Not Intervention Sarscov2 Infection1

Active Sponsors

  • European Union1
  • University of Calgary1
  • Istituto Zooprofilattico Sperimentale delle Venezie1
  • University of Padova1
  • VERDI Consortium1

Top Investigators

Related Conditions

  • Pneumonia Viral1
  • Diagnostics1
  • Sarscov2 Infection1
  • Pediatric All1
  • Covid191

Activity Timeline